Literature DB >> 17371953

NK cells and cancer.

Loris Zamai1, Cristina Ponti, Prisco Mirandola, Giuliana Gobbi, Stefano Papa, Laura Galeotti, Lucio Cocco, Marco Vitale.   

Abstract

In this review, we overview the main features and functions of NK cells, focusing on their role in cell-mediated immune response to tumor cells. In parallel, we discuss the information available in the field of NK cell receptors and offer a wide general overview of functional aspects of cell targeting and killing, focusing on the recent acknowledgments on the efficacy of NK cells after cytokine and mAb administration in cancer therapy. Since efficacy of NK cell-based immunotherapy has been proven in KIR-mismatch regimens or in TRAIL-dependent apoptosis, the ability to manipulate the balance of activating and inhibitory receptors on NK cells and of their cognate ligands, as well as the sensitivity of tumor cells to apoptosis, opens new perspectives for NK cell-based immunotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17371953     DOI: 10.4049/jimmunol.178.7.4011

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.

Authors:  Hans Klingemann; Carrie Grodman; Elliott Cutler; Marvin Duque; Diane Kadidlo; Andreas K Klein; Kellie A Sprague; Kenneth B Miller; Raymond L Comenzo; Tarun Kewalramani; Neng Yu; Richard A Van Etten; David H McKenna
Journal:  Transfusion       Date:  2012-06-28       Impact factor: 3.157

2.  Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats.

Authors:  Ryan W Logan; Changqing Zhang; Sengottuvelan Murugan; Stephanie O'Connell; Dale Levitt; Alan M Rosenwasser; Dipak K Sarkar
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

3.  Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response.

Authors:  Romulus Breban; Aurelie Bisiaux; Claire Biot; Cyrill Rentsch; Philippe Bousso; Matthew L Albert
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 4.  Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery.

Authors:  Bo Jiao; Chun Yang; Nian-Nian Huang; Ning Yang; Jia Wei; Hui Xu
Journal:  Curr Med Sci       Date:  2018-12-07

5.  Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study.

Authors:  Shaun Wen Huey Lee; Men Long Liong; Kah Hay Yuen; John N Krieger
Journal:  Complement Ther Med       Date:  2014-10-23       Impact factor: 2.446

6.  Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy.

Authors:  Run Xiao; Anthony G Mansour; Wei Huang; Logan A Chrislip; Ryan K Wilkins; Nicholas J Queen; Youssef Youssef; Hsiaoyin C Mao; Michael A Caligiuri; Lei Cao
Journal:  Mol Ther       Date:  2019-02-16       Impact factor: 11.454

7.  Genetic diversity and tumor immunesurveillance.

Authors:  Mari Hirvinen; Vincenzo Cerullo
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 8.  NK cells: key to success of DC-based cancer vaccines?

Authors:  Eva Lion; Evelien L J M Smits; Zwi N Berneman; Viggo F I Van Tendeloo
Journal:  Oncologist       Date:  2012-08-20

Review 9.  Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

10.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.